<p>Microbix Biosystems Inc. has announced that it has begun supplying its quality assessment products (QAPs) to the College of American Pathologists (CAP) for use in CAP’s clinical laboratory proficiency-testing (PT) and external quality assessment (EQA) programs. The company confirmed that multiple QAP product SKUs have been provided to CAP and are being used at clinical laboratories participating in CAP PT/EQA programs. The specific programs using Microbix QAPs remain confidential to maintain the integrity of the proficiency testing process. Microbix aims to support additional CAP PT/EQA programs and expand its offerings in the future. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Microbix Biosystems Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1134904) on February 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)</p>

Reuters

Proshares Ultra Nasdaq Biotech

iShares Biotechnology ETF

VanEck Biotech ETF

Invesco Biotechnology & Genome ETF

First Trust NYSE Arca Biotech Index Fd

MBX Biosciences

Invesco Nasdaq Biotechnology ETF

Direxion S&P Biotech Bear 3X

ALPS Medical Breakthrough

VG Health

Ark Genomic Revolution ETF

iShares US Pharma

SPDR S&P Biotech

Health Care Select Sector SPDR

Rapid Micro Biosystems

SPDR S&P Health Equip

iShares US Medical Devices

Microbix Biosystems Secures CAP Order for Quality Assessment Products